Live
- Horoscope Today: Astrological Prediction November 6, 2024 for All Zodiac Signs
- GAIL clocks net profit of Rs 2,672 crore in Q2
- Dubai Fitness Challenge is Here!
- Sr Men's National Hockey: Delhi, Karnataka, Bengal, A.P. win group matches on Day 2
- ‘Nation is proud of you’: West Bengal Guv to GRSE on laying keels of two NGOPVS
- KLH Bachupally Campus Promotes Unity Through Community Initiatives
- Kirttane, Kapadia bag golden double as India wins 14 medals in Asia Pickleball Games
- IDFC FIRST Bank leads the way in revolutionising real-time tracking of money sent abroad through Swift GPI
- Gurugram: 11 projects of GMDA worth Rs 249.77 crores approved
- Samsung R&D Institute, Bangalore Sets Up a State-of-the-Art Linguistics Lab focused on Artificial Intelligence and Machine Learning, Jointly with Garden City University, Bangalore
Dr Reddy’s launches e-com website for diabetic patients
Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, on Wednesday announced the launch of its first direct-to-consumer (D2C) e-commerce...
Dr Reddy’s Laboratories Ltd, a global pharmaceutical company, on Wednesday announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients.Launched by DRL’swholly-owned subsidiary, Svaas Wellness Limited, the website will host the Celevida range of products and third-party brands that offer product portfolio for diabetic patients.
Since its launch in 2019, Celevida has been the flagship nutrition brand for dietary management of diabetes. The website currently delivers to more than 18,000 pin codes across India.
M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), said: “We are happy to announce the launch of ‘Celevida
Wellness’ as a direct-to-consumer e-commerce platform by our subsidiary Svaas Wellness.
